Clinical Trials Browser

Phase 2 × OTHER × HER2-Negative Breast Cancer × Clear all

NCT07396454 2026-02-09

Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib

Phase 2 Recruiting

HER2-Negative Breast Cancer

NCT03989089 2024-12-18

Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation

Phase 2 Active not recruiting

HER2-Negative Breast Cancer